Resources

The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.

Showing 506 Results

Observational Studies in a Learning Health System

Tomorrow morning, the Institute of Medicine (IOM), in conjunction with the Patient-Centered Outcomes Research Institute (PCORI), will kick off its two-day workshop on the use of observational studies…

More on Individual Treatment Effects and Research Studies

Researchers are well aware that it can be difficult to parse out which subgroups will experience different treatment responses, even when they have large numbers of studies available to explore. Some…

Say GRACE! Principles for Observational Studies

Research critics often point to methodological weaknesses inherent in observational studies, coupled with the lack of standard principles to assess their quality, as practical limitations to their…

RCTs vs. Observational Studies?

Randomized controlled trials (RCTs) can be the best way to answer a particular health care question, but they don’t reflect the real world, explains Dr. Robert Dubois, chief science officer at the…

Why Observational Studies Matter

Next week, the Institute of Medicine (IOM), in conjunction with the Patient-Centered Outcomes Research Institute (PCORI), will be holding a two-day workshop on the use of observational studies in a…

NPC's Dr. Dubois Talks ACO Expectations at AMCP Meeting

NPC's Chief Science Officer Dr. Robert Dubois chats with the American Journal of Managed Care about expectations for implementing accountable care organizations. Watch the video, which was taped…

NPC’s Dr. Graff: Individual Treatment Effects Matter

Dr. Jennifer Graff, NPC’s director for comparative effectiveness research, highlighted one of the key challenges in determining the best treatment options for patients during her presentation at the…

NPC Examines CER as Health Reform Takes Hold

What's on the National Pharmaceutical Council's (NPC) radar for 2013? NPC President Dan Leonard takes a closer look at comparative effectiveness research (CER), state health exchanges and benefits,…

US v. Caronia: Related Resources

The 2nd U.S. Circuit Court of Appeals' recent decision on United States vs. Caronia raises a big question for the pharmaceutical industry: will the decision have broader applicability to comparative…